1.360CAD0.00%Mkt Cap: 10.56M $P/E: —7d ago
Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets AGGRASTAT injection, a glycoprotein GP IIb/IIIa recepto…